NEUROTECH INTERNATIONAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.077 AUD | +2.67% |
|
-6.10% | +11.59% |
| 04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
| 04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 0.0910 | 0.1200 | 0.1200 |
| Spread/Res. | -15.38% | -35.83% | -35.83% |
| Spread/Supp. | +5.48% | +45.28% | +26.23% |
| Support | 0.0730 | 0.0530 | 0.0610 |
- Stock Market
- Equities
- NTI Stock
- Charts Neurotech International Limited